Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Diseases of the Thyroid

  Free Subscription

Articles published in Eur Thyroid J

Retrieve available abstracts of 43 articles:
HTML format

Single Articles

    February 2024
  1. HOU S, Sun Y, Yang Z, Tang M, et al
    The diagnostic value of GICA used for intraoperative lymph node FNA-Tg measurement to evaluate thyroid cancer metastases.
    Eur Thyroid J. 2024;13:e230182.
    PubMed     Abstract available

  2. HOLMBERG M, Malmgren H, Berglund PF, Johansson B, et al
    Psychiatric complications in Graves' disease.
    Eur Thyroid J. 2024;13:e230247.
    PubMed     Abstract available

  3. GIANOUKAKIS AG, Choe JH, Bowles DW, Brose MS, et al
    Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
    Eur Thyroid J. 2024;13:e230039.
    PubMed     Abstract available

    December 2023
  4. MAVROMATI M, Saiji E, Demarchi MS, Lenoir V, et al
    Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing.
    Eur Thyroid J. 2023;12:e230114.
    PubMed     Abstract available

  5. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
    Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
    Eur Thyroid J. 2023;12:e230105.
    PubMed     Abstract available

  6. GAMBALE C, Prete A, Contartese L, Torregrossa L, et al
    Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients.
    Eur Thyroid J. 2023;12:e230052.
    PubMed     Abstract available

  7. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
    Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
    Eur Thyroid J. 2023;12:e230049.
    PubMed     Abstract available

  8. JANSEN HI, van Haeringen M, Bouva MJ, den Elzen WPJ, et al
    Optimizing the Dutch newborn screening for congenital hypothyroidism by incorporating amino acids and acylcarnitines in a machine learning-based model.
    Eur Thyroid J. 2023;12:e230141.
    PubMed     Abstract available

  9. WU L, Vaccarella S, Feng CY, Dal Maso L, et al
    Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study.
    Eur Thyroid J. 2023;12:e230127.
    PubMed     Abstract available

  10. RIIS KR, Larsen CB, Medici BR, Jensen CZ, et al
    Hypothyroid women have persistently higher oxidative stress compared to healthy controls.
    Eur Thyroid J. 2023;12:e230167.
    PubMed     Abstract available

  11. WAN Z, Li Y, Dong X, Kang Y, et al
    Influence of metabolic syndrome and lifestyle factors on thyroid nodules in Chinese adult men: a cross-sectional study.
    Eur Thyroid J. 2023;12:e230168.
    PubMed     Abstract available

  12. CONSTANTINESCU SM, Hospel J, Daumerie C, Alexopoulou O, et al
    Significance of thyroperoxidase and thyroglobulin antibodies in medically treated Graves' disease.
    Eur Thyroid J. 2023;12:e230193.
    PubMed     Abstract available

  13. TSENG HH, Lin YB, Lin KY, Lin CH, et al
    A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan.
    Eur Thyroid J. 2023;12:e230162.
    PubMed     Abstract available

  14. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
    Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
    Eur Thyroid J. 2023;12:e230049.
    PubMed     Abstract available

  15. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
    Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
    Eur Thyroid J. 2023;12:e230105.
    PubMed     Abstract available

  16. KYRILLI A, Tacelli N, Russo L, Lebrun L, et al
    Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.
    Eur Thyroid J. 2023;12:e230135.
    PubMed     Abstract available

  17. LEE YJ, Choi YH, Lim YH, Kim BN, et al
    Effects of iodine status on thyroid volume and goiter in children living in an iodine-replete area.
    Eur Thyroid J. 2023;12:e230219.
    PubMed     Abstract available

  18. HUSTED L, Rodgaard-Hansen S, Lundgaard MH, Uldall Torp NM, et al
    Biochemical markers of renal function and maternal hypothyroidism in early pregnancy.
    Eur Thyroid J. 2023;12:e230157.
    PubMed     Abstract available

  19. WON HR, Kim MG, Kim MS, Chang JW, et al
    Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence.
    Eur Thyroid J. 2023;12:e230195.
    PubMed     Abstract available

  20. BAHCECIOGLU AB, Gursoy A, Dizbay Sak S, Ilgan S, et al
    The sonographer's and pathologist's perspective of echogenic microfoci in papillary thyroid carcinoma.
    Eur Thyroid J. 2023;12:e230108.
    PubMed     Abstract available

  21. JIA HY, Chen J, Zhai ZX, Fan WW, et al
    Characterization of thyroid metastasis from clear cell renal cell carcinoma on ultrasonography: a report of three cases and literature review.
    Eur Thyroid J. 2023;12:e230121.
    PubMed     Abstract available

    October 2023
  22. DURANTE C, Hegedus L, Czarniecka A, Paschke R, et al
    2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.
    Eur Thyroid J. 2023;12:e230067.
    PubMed     Abstract available

  23. PINAR-GUTIERREZ A, Romero-Lluch AR, Duenas-Disotuar S, de Lara-Rodriguez I, et al
    Bone metastases from differentiated thyroid cancer: characteristics and prognostic factors in a multicenter series.
    Eur Thyroid J. 2023;12:e230086.
    PubMed     Abstract available

  24. FU J, Fan Z, He L, Liu Q, et al
    Circadian clock disruption in autoimmune thyroiditis.
    Eur Thyroid J. 2023;12:e230035.
    PubMed     Abstract available

  25. URSEM SR, Boelen A, Hillebrand JJ, den Elzen WPJ, et al
    How low can we (reliably) go? A method comparison of thyroid-stimulating hormone assays with a focus on low concentrations.
    Eur Thyroid J. 2023;12:e230123.
    PubMed     Abstract available

  26. MANSO J, Censi S, Clausi C, Piva I, et al
    Circulating miR-146a predicts glucocorticoid response in thyroid eye disease.
    Eur Thyroid J. 2023;12:e230083.
    PubMed     Abstract available

    August 2023
  27. WU J, Hu X, Seal P, Amin P, et al
    Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study.
    Eur Thyroid J. 2023;12:e230110.
    PubMed     Abstract available

  28. HALENKA M, Munteanu H, Obereigneru R, Dohnal R, et al
    Ethanol ablation of thyroid cysts in the young with a focus on efficacy and quality of life.
    Eur Thyroid J. 2023;12:e230085.
    PubMed     Abstract available

  29. SOLDEVILA B, Velasco I, Munoz C, Diaz Y, et al
    Longitudinal trajectories of maternal TSH in healthy pregnant women in Catalonia.
    Eur Thyroid J. 2023;12:e230016.
    PubMed     Abstract available

  30. CAPDEVILA J, Deandreis D, Durante C, Leboulleux S, et al
    Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.
    Eur Thyroid J. 2023;12:e230068.
    PubMed     Abstract available

  31. CAMPI I, Dell'Acqua M, Stellaria Grassi E, Cristina Vigone M, et al
    Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart.
    Eur Thyroid J. 2023;12:e230012.
    PubMed     Abstract available

  32. PERROS P, Hegedus L
    Teprotumumab in thyroid eye disease: wonder drug or great divider?
    Eur Thyroid J. 2023;12:e230043.
    PubMed     Abstract available

  33. JU N, Hou L, Song H, Qiu Z, et al
    TSH >/=30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer.
    Eur Thyroid J. 2023;12:e220219.
    PubMed     Abstract available

    July 2023
  34. NILSSON JN, Siikanen J, Condello V, Jatta K, et al
    Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.
    Eur Thyroid J. 2023;12:e230099.
    PubMed     Abstract available

  35. MO C, Chen H, Zhang Q, Guo Y, et al
    Central hyperthyroidism combined with Graves' disease: case series and review of the literature.
    Eur Thyroid J. 2023;12:e220223.
    PubMed     Abstract available

  36. BENABDELKAMEL H, Jaber MA, Dahabiyeh LA, Masood A, et al
    Metabolomic profile of patients on levothyroxine treatment for hypothyroidism.
    Eur Thyroid J. 2023;12:e230062.
    PubMed     Abstract available

  37. BOELEN A, Zwaveling-Soonawala N, Heijboer AC, van Trotsenburg ASP, et al
    Neonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch?
    Eur Thyroid J. 2023;12:e230041.
    PubMed     Abstract available

  38. DAL MASO L, Pierannunzio D, Francisci S, De Paoli A, et al
    Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001-2018.
    Eur Thyroid J. 2023;12:e230051.
    PubMed     Abstract available

  39. SOARES MN, Borges-Canha M, Neves C, Neves JS, et al
    The role of Graves' disease in the development of thyroid nodules and thyroid cancer.
    Eur Thyroid J. 2023;12:e230055.
    PubMed     Abstract available

  40. JOHANSSON B, Holmberg M, Skau S, Malmgren H, et al
    The relationship between mental fatigue, depression, and cognition in Graves' disease.
    Eur Thyroid J. 2023;12:e230040.
    PubMed     Abstract available

  41. COLOMBO C, Ceruti D, De Leo S, Bilo G, et al
    Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.
    Eur Thyroid J. 2023;12:e230047.
    PubMed     Abstract available

    June 2023
  42. DIAS D, Damasio I, Marques P, Simoes H, et al
    Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin.
    Eur Thyroid J. 2023;12:e220227.
    PubMed     Abstract available

  43. KARA C, Mammadova J, Abur U, Gumuskaptan C, et al
    Genetic testing can change diagnosis and treatment in children with congenital hypothyroidism.
    Eur Thyroid J. 2023;12:e220212.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.